Prelude Capital Management’s Revolution Medicines RVMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RVMD
BBA
DGM
Prelude Capital Management's RVMD Position: Q3 2026 in Review
Prelude Capital Management sold out of Revolution Medicines (RVMD) in Q3 2026, closing a stake of 10,997 shares — an estimated $2.06M sold.
Prelude Capital Management first reported a position in RVMD in Q2 2023 and held it in 4 quarters. The position peaked at $2.06M in Q2 2026. 760 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.
- Prelude Capital Management reported no remaining Revolution Medicines position as of Q3 2026 after selling out during the quarter.
- Prelude Capital Management sold 10,997 Revolution Medicines shares in Q3 2026, an estimated $2.06M.
- Prelude Capital Management first reported a position in Revolution Medicines in Q2 2023 and held it in 4 quarters.
- Prelude Capital Management's Revolution Medicines position peaked at $2.06M in Q2 2026.
- 760 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.
Based on Prelude Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.